| # | Drug | Count |
|---|---|---|
| 0 | BEVACIZUMAB | 27 |
| 1 | PREDNISONE | 27 |
| 2 | AZATHIOPRINE | 13 |
| 3 | PREDNISOLONE | 10 |
| 4 | PREDNISOLONE ORAL | 10 |
| 5 | PREDNISOLONE ORAL SOLUTION | 10 |
| 6 | RANIBIZUMAB | 10 |
| 7 | VALACYCLOVIR HYDROCHLORIDE | 10 |
| 8 | DEXAMETHASONE | 9 |
| 9 | PREDNISOLONE ACETATE | 9 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | REVAKINAGENE TARORETCEL-LWEY | 1 | 0.1429 |
| 1 | HYPOCHLOROUS ACID | 1 | 0.0093 |
| 2 | BEVACIZUMAB-ADCD | 1 | 0.0049 |
| 3 | TROPICAMIDE | 4 | 0.0024 |
| 4 | FOSCARNET SODIUM | 7 | 0.0017 |
| 5 | BODY CLEANSER | 1 | 0.0014 |
| 6 | PREDNISOLONE ACETATE | 9 | 0.0008 |
| 7 | PYRIMETHAMINE | 1 | 0.0008 |
| 8 | GANCICLOVIR SODIUM | 8 | 0.0007 |
| 9 | GATIFLOXACIN | 1 | 0.0006 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Dihydrofolate Reductase Inhibitor Antimalarial [EPC] | 1 | 0.0008 |
| 1 | alpha-1 Adrenergic Agonist [EPC] | 3 | 0.0007 |
| 2 | Cytomegalovirus Nucleoside Analog DNA Polymerase Inhibitor [EPC] | 8 | 0.0004 |
| 3 | Plasma Volume Expander [EPC] | 1 | 0.0003 |
| 4 | Anticholinergic [EPC] | 5 | 0.0003 |
| 5 | Antihypoglycemic Agent [EPC] | 1 | 0.0002 |
| 6 | Blood Viscosity Reducer [EPC] | 1 | 0.0002 |
| 7 | Antiseptic [EPC] | 1 | 0.0002 |
| 8 | Vascular Endothelial Growth Factor Inhibitor [EPC] | 42 | 0.0002 |
| 9 | SARS-CoV-2 Nucleotide Analog RNA Polymerase Inhibitor [EPC] | 3 | 0.0002 |